2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
US7323472B2 · kind B2 · utility
11Cited by
26References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2001 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Apr 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment, including prophylaxis of inflammation enhanced cough in a mammal in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.